BillionToOne Competitors and Similar CompaniesClear all
BillionToOne's competitors and similar companies include ReCode Therapeutics and VivoSensMedical.
 BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  VivoSensMedical VivoSensMedical is a company providing diagnostic tools for the indications of autoimmune diseases, chronobiology, and women’s health. | |
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Menlo Park, US HQ | Locations Leipzig, DE HQ |
Employees | Employees 620 | Employees 1062% decrease | Employees 12 |
Funding | |||
Total funding raised | Total funding raised $ 87.5m | Total funding raised $ 82m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View companyVivoSensMedical
HQ
Leipzig, DE
Employees
12
VivoSensMedical is a company providing diagnostic tools for the indications of autoimmune diseases, chronobiology, and women’s health.
View company